Cardiac implantable electronic devices (CIEDs) are currently used in the clinic to address arrhythmias. The main limitations and complications associated with CIEDs are mostly related to the mechanical (synthetic) structure of the device components (e.g., lead infection and rupture) and are potentially life-threatening for patients, with a significant impact on healthcare costs. A “no-mechanical device solution” would be desirable. In literature, biological pacemakers have been, recently, developed using gene- and cell-based research strategies, but to date, those technologies are far from clinical translation due to several clinical implications (e.g., cell migration, potential teratogenic effects). Furthermore, mechanoelectrical and automaticity pathways have been, newly, employed to reproduce biological features of the heart into biohybrid platforms. This thesis project aims to overcome such limitations by combining cell-based strategies with principles of regenerative medicine. Our engineered contractile patch will be constituted by induced pluripotent stem cells, programmed to acquire a myocardial phenotype. Cells will be seeded upon a biological scaffold, derived from swine cardiac decellularized extracellular matrix. The patch, so generated, will serve not only as an implantable stimulating device but also, prospectively, as a diagnostic tool for patients’ disease characterization.

Cardiac implantable electronic devices (CIEDs) are currently used in the clinic to address arrhythmias. The main limitations and complications associated with CIEDs are mostly related to the mechanical (synthetic) structure of the device components (e.g., lead infection and rupture) and are potentially life-threatening for patients, with a significant impact on healthcare costs. A “no-mechanical device solution” would be desirable. In literature, biological pacemakers have been, recently, developed using gene- and cell-based research strategies, but to date, those technologies are far from clinical translation due to several clinical implications (e.g., cell migration, potential teratogenic effects). Furthermore, mechanoelectrical and automaticity pathways have been, newly, employed to reproduce biological features of the heart into biohybrid platforms. This thesis project aims to overcome such limitations by combining cell-based strategies with principles of regenerative medicine. Our engineered contractile patch will be constituted by induced pluripotent stem cells, programmed to acquire a myocardial phenotype. Cells will be seeded upon a biological scaffold, derived from swine cardiac decellularized extracellular matrix. The patch, so generated, will serve not only as an implantable stimulating device but also, prospectively, as a diagnostic tool for patients’ disease characterization.

Integration of cell programming and tissue engineering for in-vitro modeling of a cardiac stimulation patch: a game-changer in the clinical scenario

TOMAS, ALICE
2021/2022

Abstract

Cardiac implantable electronic devices (CIEDs) are currently used in the clinic to address arrhythmias. The main limitations and complications associated with CIEDs are mostly related to the mechanical (synthetic) structure of the device components (e.g., lead infection and rupture) and are potentially life-threatening for patients, with a significant impact on healthcare costs. A “no-mechanical device solution” would be desirable. In literature, biological pacemakers have been, recently, developed using gene- and cell-based research strategies, but to date, those technologies are far from clinical translation due to several clinical implications (e.g., cell migration, potential teratogenic effects). Furthermore, mechanoelectrical and automaticity pathways have been, newly, employed to reproduce biological features of the heart into biohybrid platforms. This thesis project aims to overcome such limitations by combining cell-based strategies with principles of regenerative medicine. Our engineered contractile patch will be constituted by induced pluripotent stem cells, programmed to acquire a myocardial phenotype. Cells will be seeded upon a biological scaffold, derived from swine cardiac decellularized extracellular matrix. The patch, so generated, will serve not only as an implantable stimulating device but also, prospectively, as a diagnostic tool for patients’ disease characterization.
2021
Integration of cell programming and tissue engineering for in-vitro modeling of a cardiac stimulation patch: a game-changer in the clinical scenario
Cardiac implantable electronic devices (CIEDs) are currently used in the clinic to address arrhythmias. The main limitations and complications associated with CIEDs are mostly related to the mechanical (synthetic) structure of the device components (e.g., lead infection and rupture) and are potentially life-threatening for patients, with a significant impact on healthcare costs. A “no-mechanical device solution” would be desirable. In literature, biological pacemakers have been, recently, developed using gene- and cell-based research strategies, but to date, those technologies are far from clinical translation due to several clinical implications (e.g., cell migration, potential teratogenic effects). Furthermore, mechanoelectrical and automaticity pathways have been, newly, employed to reproduce biological features of the heart into biohybrid platforms. This thesis project aims to overcome such limitations by combining cell-based strategies with principles of regenerative medicine. Our engineered contractile patch will be constituted by induced pluripotent stem cells, programmed to acquire a myocardial phenotype. Cells will be seeded upon a biological scaffold, derived from swine cardiac decellularized extracellular matrix. The patch, so generated, will serve not only as an implantable stimulating device but also, prospectively, as a diagnostic tool for patients’ disease characterization.
Tissue engineering
hiPSCs
Biological pacemaker
Microfluidics
Cardiac generation
File in questo prodotto:
File Dimensione Formato  
Tomas_Alice.pdf

accesso riservato

Dimensione 3.49 MB
Formato Adobe PDF
3.49 MB Adobe PDF

The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12608/42303